Investors Buy Large Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading on Wednesday. Traders acquired 1,885 put options on the company. This is an increase of approximately 1,101% compared to the average daily volume of 157 put options.

Evelo Biosciences Price Performance

NASDAQ:EVLO remained flat at $0.00 during trading hours on Thursday. 11 shares of the company’s stock traded hands, compared to its average volume of 1,492. The stock has a market cap of $8,541.00, a price-to-earnings ratio of 0.00 and a beta of 1.29. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $0.76. The business’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.03.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.